Geometry.Net - Health_Conditions: Non-hodgkins Lymphoma

Tony's Cancer Page - Non-Hodgkins Lymphoma (NHL)
THIS WEBSITE HAS MOVED TO A NEW ADDRESS! Please change your favoritesor bookmarks to the following http//inspirezone.org/tonycan.htm.
http://www.geocities.com/Heartland/Bluffs/7608/tonycan.htm
Tony's Cancer Page - Non-Hodgkins Lymphoma (NHL)
A long term survivor (diagnosed 1988) of non-Hodgkin's Lymphoma describes his original symptoms, diagnosi Category Health Conditions and Diseases Lymphoma Personal Pages INTRODUCTION. The purpose of this page is to briefly report on my experiencewith Cancer (nonhodgkins lymphoma), which began in May of 1988.
http://www.inspirezone.org/tonycan.htm

Extractions: BACKGROUND In 1988, I was a very active and healthy person. I had spent my 42 years basically without any health problems. No broken bones, no trips to the hospital for any reason, no doctor visits except for routine check-ups. I lived a very healthy lifestyle, which involved running 5 to 10 miles daily and competing in weekend road races along with my wife Donna. I had a very healthy diet consisting of a low-fat, high carbohydrate regimen. I coached cross-country at the High School and each day, trained with my team and then ran with Donna when I got home from practice. I thought that I was probably one of the healthiest people in Toccoa, Georgia. That's when I started having problems. FAMILY REACTION One of the toughest parts was telling my family. I was doing fine at first but when I saw my Daddy cry, it broke me up. My wife was a strong, loving, pillar of support throughout the ordeal and my Mom and Dad and my two brothers and their families were always there and more than willing to do anything that they could to help out. I drew most of my strength from the prayers of my family and of my Church family and my extended Christian Family. Early on, I turned the whole situation over to God who had sent Jesus to be my personal Savior. I understood from the beginning that as a Christian, I was not promised that I would never have problems, but I was promised that He would never leave me or forsake me.
Information On Non-hodgkins Lymphoma Cancer And Radioimmunotherapy. Articles And
hodgkins disease Targeted Information for Patients With nonhodgkins lymphoma.
http://www.lymphomainnovations.com/lymphomainnovations/nhl.asp
Radioimmunotherapy For B Cell Non-Hodgkins Lymphoma
Radioimmunotherapy for B Cell nonhodgkins lymphoma. IDEC PharmaceuticalsCorporation has announced the final results of two pivotal
http://www.bloodline.net/stories/storyReader$2304

Extractions: Login IDEC Pharmaceuticals Corporation has announced the final results of two pivotal trials of Zevalin(TM) (Ibritumomab Tiuxetan), an investigational radioimmunotherapy, during oral presentations at the 42nd Annual Meeting of the American Society of Hematology (ASH). Thomas E. Witzig, M.D. of the Mayo Clinic, Rochester, MN, delivered an oral presentation of a Phase III randomized, controlled study of 143 patients with relapsed or refractory low grade, follicular, or CD20-positive transformed B-cell non-Hodgkins lymphoma (NHL). He noted that the Zevalin combined with Rituxan arm of the study showed an overall response rate (ORR) of 80 percent, compared to the Rituxan(R) (Rituxumab) alone control arm, which showed an overall response rate of 56 percent. A treatment course for Zevalin includes a Rituxan infusion (250 mg/m.2) on day one, followed by infusions of Rituxan (250 mg/m2) and Zevalin (at a standard radiation dose of 0.4 mCi/kg of patient body weight) on day eight. A treatment course of the Rituxan control consisted of four weekly doses of 375 mg/m2 of Rituxan.
NON-HODGKINS LYMPHOMA
nonhodgkins lymphoma. JULY 2002 NON-HODGKINS'S LYMPHOMA. When I foundout my husband Jim had stage four, Non-Hodgkin's Lymphoma
http://home.thirdage.com/friendship/dreamchaser22/lymphoma.html

Extractions: Your body contains white blood cells called "lymphocytes" that help protect against disease and infection. When these cells become cancerous, the result is called a lymphoma. Non-Hodgkin's lymphoma is one of two main types of lymphoma. The other type is called Hodgkin's disease or Hodgkin's lymphoma. When lymphoma cells begin to multiply they may form a tumor, a clump of cancer cells. They can also spread to other areas of the body. Lymphomas are usually found in the lymph modes or bone marrow. There may be more than 20 types of NHL. Usually, NHL is divided into three types:
Non-Hodgkins Lymphoma - Published In AIDS, March 30, 2001
nonhodgkins lymphoma (PDF of entire published article attached) Thislarge study published in AIDS (2001 March 30; 15(5)629-633
http://www.natap.org/2001/may/nhl050601.htm

Extractions: PDF of entire published article attached) This large study published in AIDS (2001 March 30; 15(5):629-633) reports that both KS and NHL incidence have declined since June 1996 (the advent of HAART) but that the incidence of KS has declined more than NHL. Time period Incidence/1000 person-years (95% CI) KS July '94 -June '96 Jan '96 -Dec '98 NHL July '94 -June '96 June '96-Dec '98 Australian researchers report: This study finds decreasing incidence rates of both NHL and KS in people with HIV since the introduction of potent anti-retroviral therapies. For NHL, incidence had been increasing prior to 1996, and this increase masked the decrease since the introduction of the new HIV therapies when long-term trends were considered. The increase in NHL incidence in the early epidemic, which was also seen for KS, may have been related to increasing immune deficiency of the cohort. This study also confirms at a population level the previously described decreases in the incidence of KS during the 1990s. This decrease began before the introduction of the new therapies. KS has decreased in incidence by far more than NHL, so that NHL is now the most common AIDS-associated cancer in Australia. It is unclear why rates of NHL appear to be decreasing more slowly than other AIDS-associated illnesses, but there are at least three possible explanations. First, unlike KS, NHL does not appear to be due to a specific infective agent, so partial immune restoration may be less effective in prevention. Second, NHL occurs at a less severe degree of immune deficiency than most other AIDS-associated illnesses. Third, there is evidence that chronic stimulation of the immune system is a risk factor for AIDS-related NHL, and potent combination antiretroviral therapy may be only partially effective at reversing this immune stimulation [14,15]. (Editorial note from Jules Levin: does this make a case towards earlier treatment for HIV to avoid immune decline and active viral stimulation which treatment inhibitis? Perhaps this is one consideration among many. Also to be considered, is what's the risk of getting NHL whether therapy is started earlier or later?)
Idarubicin (IDA) For Older Non-Hodgkins Lymphoma Patients
a timely medical meeting newsletter IDARUBICIN (IDA) FOR OLDER NONHODGKINSLYMPHOMA PATIENTS F.Cabanillas, MD, University of Texas
http://www.meds.com/conrad/ash/cabanillas.html

Extractions: Conrad Notes Index ASH Index a timely medical meeting newsletter IDARUBICIN (IDA) FOR OLDER NON-HODGKINS LYMPHOMA PATIENTS Adriamycin (ADRIA) with low dose IDA in a complex regimen showed less myelosupression and lethal toxicity. Please see US package inserts on idarubicin ( Idamycin ) and doxorubicin ( Adriamycin Background on IDA and ADRIA As anthracyclines, both drugs produce cytotoxicity by binding to nucleic acids, interfering with nucleotide replication, and by blocking DNA and RNA polymerases. The cytocidal activity may be due to interaction with the enzyme topoisomerase II resulting in DNA-cleavable complexes. IDA is more lipophilic, penetrates cells faster, and is superior to ADRIA in treating acute myeloid leukemia (AML). Patient selection Cabanillas and coworkers entered 156 APPNHL patients presenting an unfavorable tumor score predictive of a 3-year survival rate of 28% using standard CHOP therapy. (CHOP is the acronym for a regimen of cyclophosphamide, ADRIA, vincristine, and prednisone.) Fifty-two (37%) of the 142 evaluable patients were >60 years old and at increased risk. In view of the patients' poor prognosis, all received a complex regimen as basic treatment. One group of patients had low-dose IDA instead of ADRIA according to random assignment. The basic regimen, called ATT, consisted of Solu-Medrol
Frequently Asked Questions About Non-Hodgkins Lymphoma
Frequently Asked Questions About NonHodgkin's Lymphoma Information from TheJames Cancer Hospital and Solove Research Institute. lymphoblastic lymphoma.
http://www.jamesline.com/output/content/cainfo/nhodhome/nhodfaq.htm

Extractions: Information from The James Cancer Hospital and Solove Research Institute 1. What are Non-Hodgkin's Lymphomas? ANSWER: Lymphoma is a general term for cancers that develop in the lymphatic system. The most common type is called Hodgkin's. All other Lymphomas are grouped together and are called non-Hodgkin's lymphomas. The lymphatic system is part of the body's immune defense system. Its job is to help fight diseases and infection. The lymphatic system includes a network of thin tubes that branch, like blood vessels, into tissues throughout the body. Lymphatic vessels carry lymph, a colorless, watery fluid that contains infection-fighting cells called lymphocytes. Along this network of vessels are small, bean-shaped organs called lymph nodes. Clusters of lymph nodes are found in the underarms, groin, neck, chest, and abdomen. Other parts of the lymphatic system are the spleen, thymus, tonsils, and bone marrow. Lymphatic tissue is also found in other parts of the body, including the stomach, intestines, and skin. Like all types of cancer, lymphomas are diseases of the body's cells. Healthy cells grow, divide, and replace themselves in an orderly manner. This process keeps the body in good repair.
Lymphoma Non-Hodgkins
Trial to Evaluate Preliminary Safety Efficacy of Hu1D10 in Patients w Relapsedor Refractory Grades I, II, or III BCell non-hodgkins lymphoma (inc Follicular
http://www.jamesline.com/output/content/CCCsite/ccc/Protocols/nhod.htm

Extractions: Lymphoma Non-Hodgkins Type of Protocol IRB Consent Description Contact Name and Number CALGB 109901 Minimal Ablation and Cellular Immune Therapy of Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Low-Grade Non-Hodgkin's Lymphoma, and Mantle Cell Lymphoma with Allogeneic Donor Stem Cells For more information, please contact The James Line at 1-800-293-5066 or email at cancerinfo@jamesline.com CALGB 50103 Phase II Study of Dose-Adjusted Epoch-Rituximab (EPOCH-R) Chemotherapy for Patients with Previously Untreated Aggressive CD20+ B-Cell Non-Hodgkin's Lymphoma (NHL) Histo documented Stage II, III or IV NHL w no evid of indolent lymphoma. No prior chemo. No known CNS involvement. For more information, please contact The James Line at 1-800-293-5066 or email at cancerinfo@jamesline.com CALGB 59901 A Phase II Study of 506U78 (IND#52611) in Patients with Previously Systemically Untreated Cutaneous T-Cell Lymphoma (CTCL) or with Refractory/Relapsed Non-Cutaneous Peripheral T-Cell Lymphoma (PTCL) For more information, please contact The James Line at 1-800-293-5066 or email at
U-M CCC - Information Guide - Non-Hodgkins Lymphoma
Updated 11/2002. nonhodgkins lymphoma Information Guide. The purposeof this information guide is to help patients newly diagnosed
http://www.cancer.med.umich.edu/learn/pwnonhodlymphoma.htm

Extractions: Information Guide The purpose of this information guide is to help patients newly diagnosed with Non-Hodgkin's Lymphoma and their families find sources of information and support. This list is not meant to be comprehensive, but rather to provide starting points for information seeking. The materials can be found at the Patient Education Resource Center of the University of Michigan Comprehensive Cancer Center in room B1-361. Reference Available in the Patient Education Resource Center on level B-1 Lymphoma Research Foundation. Lymphoma Resource Guide . Full-text available online at the Patient Education section of the Lymphoma Research Foundation web site Pamphlets - Available in the Patient Education Resource Center on Level B-1 Lymphoma Research Foundation.
My Experience Of Non-Hodgkins Lymphoma Reviews, Ratings, Guide - Advice And Onli
Home Lifestyle Health Problems My Experience of nonhodgkins lymphoma. MyExperience of non-hodgkins lymphoma, dooyoo user rating 0% recommendation,
http://www.dooyoo.co.uk/lifestyle/health_problems/my_experience_of_non_hodgkins_

Extractions: only Health Problems My Experience of Non-Hodgkins Lymphoma dooyoo user rating recommendation var ebaylabel_quot = 'My Experience of Non-Hodgkins Lymphoma'; var ebaylabel = escape(ebaylabel_quot.replace(/"/g,'')); var ebaylink = 'http://www.dooyoo.co.uk/cya.jsp?dooyoopartnerID=0002&url=http://adfarm.mediaplex.com/ad/ck/710-3024-3218-3?MfcISAPICommand=GetResult%26query='+ebaylabel+'%26ebaytag1code=3%26ebaytag1ebayctry%26maxRecordsReturned=300%26maxRecordsPerPage=50%26SortProperty=MetaEndSort%26srchdesc=y'; document.write(''); Short Description
Non-Hodgkins Lymphoma In General Reviews, Ratings, Guide - Advice And Online Sho
Search Home Lifestyle Health Problems nonhodgkins lymphoma in general. Non-HodgkinsLymphoma in general, Be the first to rate this item!
http://www.dooyoo.co.uk/lifestyle/health_problems/non_hodgkins_lymphoma_in_gener

Extractions: only Health Problems Non-Hodgkins Lymphoma in general Be the first to rate this item! var ebaylabel_quot = 'Non-Hodgkins Lymphoma in general'; var ebaylabel = escape(ebaylabel_quot.replace(/"/g,'')); var ebaylink = 'http://www.dooyoo.co.uk/cya.jsp?dooyoopartnerID=0002&url=http://adfarm.mediaplex.com/ad/ck/710-3024-3218-3?MfcISAPICommand=GetResult%26query='+ebaylabel+'%26ebaytag1code=3%26ebaytag1ebayctry%26maxRecordsReturned=300%26maxRecordsPerPage=50%26SortProperty=MetaEndSort%26srchdesc=y'; document.write(''); Short Description Lymphoma is a general term for cancers that develop in the lymphatic system. They account for about 5 percent of all cases of cancer in this country. One type of lymphoma is called Hodgkin's disease. All other lymphomas are grouped together and are called non-Hodgkin's lymphomas. This refers to any group of cancers of lymphoid tissue that multiply unchecked. These are found mainly in the lymph nodes and spleen. Non-Hodgkin's lymphomas vary in their malignancy according to the activity of the abnormal cells. Primitive cells, or those that are poorly specialized, are most malignant. They tend to take over the lymph nodes rapidly overview reviews resources
Non-Hodgkins Lymphoma --- HealthandAge
nonhodgkins lymphoma. non-hodgkins lymphoma. January 8, 2002. Question.My sister has non-Hodgkin's lymphoma that has just recurred after 7 years.
http://www.healthandage.com/Home/gid7=61

Extractions: Answer Non-Hodgkin's lymphoma is a type of malignancy (cancer) that affects cells involved in the immune system and that mostly reside in the lymph nodes. Non-Hodgkin's lymphoma is not a single disease but a collection of numerous types of lymphoma with greatly divergent clinical presentations, prognoses, and treatments. The current classification scheme for these includes over 20 sorts. Given this broad spectrum of diseases under the general classification of non-Hodgkin's lymphoma, a complete answer to your request for information about the significance of a recurrence is not possible. For those types of non-Hodgkin's lymphoma generally referred to as "indolent" (e.g., follicular small cell, low grade), recurrences are expected, and treatment is aimed at relief of symptoms rather than prolongation of life. In contrast, in diffuse B-cell lymphoma (an intermediate grade lymphoma), treatment aimed at cure is feasible. A number of new treatments have recently been developed for several different types of lymphoma and more are being investigated. In summary, the type of non-Hodgkin's lymphoma is very important to further discuss the likelihood of recurrence. Please see the link below.
Non-Hodgkins Lymphoma --- HealthandAge
nonhodgkins lymphoma. News RELATED QUESTION . Non-HodgkinsLymphoma. January 8, 2002. Question. My sister has non-Hodgkin's
http://www.healthandage.com/Home/gm=1!gid7=61

Extractions: Answer Non-Hodgkin's lymphoma is a type of malignancy (cancer) that affects cells involved in the immune system and that mostly reside in the lymph nodes. Non-Hodgkin's lymphoma is not a single disease but a collection of numerous types of lymphoma with greatly divergent clinical presentations, prognoses, and treatments. The current classification scheme for these includes over 20 sorts. Given this broad spectrum of diseases under the general classification of non-Hodgkin's lymphoma, a complete answer to your request for information about the significance of a recurrence is not possible. For those types of non-Hodgkin's lymphoma generally referred to as "indolent" (e.g., follicular small cell, low grade), recurrences are expected, and treatment is aimed at relief of symptoms rather than prolongation of life. In contrast, in diffuse B-cell lymphoma (an intermediate grade lymphoma), treatment aimed at cure is feasible. A number of new treatments have recently been developed for several different types of lymphoma and more are being investigated. In summary, the type of non-Hodgkin's lymphoma is very important to further discuss the likelihood of recurrence. Please see the link below.
AEGiS-MMWR: Diffuse, Undifferentiated Non-Hodgkins Lymphoma Among Homosexual Mal
Click here to return to CDC MMWR main menu Diffuse, Undifferentiatednonhodgkins lymphoma among Homosexual Males United States
http://www.aegis.com/pubs/mmwr/1982/MM3121.html

Extractions: Centers for Disease Control and Prevention Patient 1: A 28-year-old hospital clerk complained of back and shoulder pain starting in early March 1981. Within a few days he had swelling of the right eye and an unsteady gait, and he was hospitalized on March 21. "Shotty" peripheral lymphadenopathy was present. A biopsy of an orbital mass and an enlarged cervical lymph node disclosed DUNHL. A myelogram revealed a T4-T6 block by an extradural mass. Radiation and chemotherapy led to complete remission. In September 1981, another tumor in the spinal cord was treated with radiation. The ensuing remission was temporary, and the patient died with disseminated DUNHL on January 15, 1982. Patient 2: A 33-year-old nurse developed a tumor in his left lower jaw in October 1981. Penicillin was given for a suspected abscess, but the mass enlarged. A biopsy on November 24 disclosed DUNHL. Tumor cells contained surface IgM, kappa type, indicating a B-cell tumor. The tumor involved a left axillary lymph node, the retroperitoneum, the bone marrow, and the meninges. Generalized "reactive" lymphadenopathy and mild splenomegaly were present. Systemic and intrathecal chemotherapy led to temporary tumor regression; the patient relapsed and died in March 1982.
Non-Hodgkins Lymphoma
nonhodgkins lymphoma.
http://gucfm.georgetown.edu/welchjj/netscut/heme_onc/NHL.html
Primary Non-Hodgkins Lymphoma Of The Breast.
Abstract number 466P. Citation Annals of Oncology, Vol 11, Suppl.4October 2000, page 103 Primary nonhodgkins lymphoma of the breast.
http://www.esmo.org/reference/abstracts00/lym/466.htm
Clinico-pathologic Characteristics Of Non-Hodgkins Lymphoma Patients At Single C
page 102 Clinicopathologic characteristics of non-hodgkins lymphomapatients at single centre in Central Anatolia. Ali Unal, Bülent
http://www.esmo.org/reference/abstracts00/lym/459.htm
UConn Health Center: News: Non-Hodgkins Lymphoma
Promising New Treatment for nonHodgkins Lymphoma Offered by UConnHealth Center. UConn Health Centers Division of Nuclear
http://health.uchc.edu/news/zevalin.htm

Extractions: What's New UConn House Call Promising New Treatment for non-Hodgkins Lymphoma Offered by UConn Health Center UConn Health Centers Division of Nuclear Medicine clinicians are among the first in Connecticut to use an innovative and promising new treatment for non-Hodgkins lymphoma, a frequently occurring cancer of the lymph system. The treatment, developed by scientists and doctors after more than a decade of work, successfully uses the chemical attraction of antibody to antigen to deliver radiation to specific cancer cells. An antigen is a protein on the surface of a cell that makes antibodies react when an immune system response is required. With that biological process in mind, the researchers engineered an antibody that binds to the CD-20 receptor cell typically present in non-Hodgkins lymphoma. The antibody, which was recently approved by the Food and Drug Administration, is known as Zevalin. The data from the Zevalin clinical trials shows tumor shrinkage and improvement in the quality of life for 80 percent of the patients, said Ronald Weiner, Ph.D., an associate professor, Department of Diagnostic Imaging and Therapeutics and one of the researchers doing the investigation. Patients with low-grade, non-Hodgkins lymphoma typically have responded positively to radiation therapy. But that therapy is imprecise and can cause damage or even kill normal cells in the areas of the cancer being treated. Using the cancer-cell specific antibody, however, physicians can attach a minimal dose of radioactive isotope to it. It is a more precise treatment than radiation therapy and so less likely to harm nearby normal cells.
Non-Hodgkins Lymphoma More Important Cause Of AIDS
July 24, 2000. nonhodgkins lymphoma more important causeof AIDS By By EMMA ROS AP Medical Writer AIDS Focus.
http://www.canoe.ca/Health0007/24_aids.html

Extractions: Inside CANOE.CA SLAM! Sports Jam! Showbiz AllPop CNEWS Webfin Money C-Health Lifewise AUTONET.CA Newsstand Travel Search eBay.ca Get away today 411 online Free E-Mail Shop.canoe.ca CareerConnection Classified Extra Match Contact Obituaries Today Restaurants Hotels Weather Horoscopes Lotteries Crossword Scoreboard News Ticker Biz Ticker Sports Ticker TV Listings Movie Listings CLIVE Concerts Mutual Funds Stocks Feedback Index Experts have known that the effectiveness of the new combination drug therapy, called highly active antiretrovirals, varies depending on which of the 26 AIDS-defining illnesses are involved. Some experts have reported suspicions the new therapy doesn't work as well for non-Hodgkins lymphoma as for the other diseases.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

21-40 of 96 Back | 1 | 2 | 3 | 4 | 5 | Next 20